Hankyel Park

Array ( [id] => 3824323 [patent_doc_number] => 05759770 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Retrovirus from the HIV group and its use' [patent_app_type] => 1 [patent_app_number] => 8/470202 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 13892 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/759/05759770.pdf [firstpage_image] =>[orig_patent_app_number] => 470202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3826913 [patent_doc_number] => 05783563 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-21 [patent_title] => 'Method for treatment or prophylaxis of venous thrombosis' [patent_app_type] => 1 [patent_app_number] => 8/470258 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67409 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/783/05783563.pdf [firstpage_image] =>[orig_patent_app_number] => 470258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4007599 [patent_doc_number] => 05879679 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-09 [patent_title] => 'Antigen-based heteropolymers and method for treating autoimmune diseases using the same' [patent_app_type] => 1 [patent_app_number] => 8/460861 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5544 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/879/05879679.pdf [firstpage_image] =>[orig_patent_app_number] => 460861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4196793 [patent_doc_number] => 06013506 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Feline leukemia virus vaccines' [patent_app_type] => 1 [patent_app_number] => 8/461920 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 8855 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013506.pdf [firstpage_image] =>[orig_patent_app_number] => 461920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3868099 [patent_doc_number] => 05763192 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique' [patent_app_type] => 1 [patent_app_number] => 8/462637 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9872 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763192.pdf [firstpage_image] =>[orig_patent_app_number] => 462637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4027237 [patent_doc_number] => 05902741 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-11 [patent_title] => 'Three-dimensional cartilage cultures' [patent_app_type] => 1 [patent_app_number] => 8/463566 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 18 [patent_no_of_words] => 12894 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/902/05902741.pdf [firstpage_image] =>[orig_patent_app_number] => 463566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3784796 [patent_doc_number] => 05821339 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-13 [patent_title] => 'Compositions and methods for treatment of herpesvirus infections' [patent_app_type] => 1 [patent_app_number] => 8/458568 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 25 [patent_no_of_words] => 12067 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/821/05821339.pdf [firstpage_image] =>[orig_patent_app_number] => 458568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3784580 [patent_doc_number] => 05840524 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Granulocyte chemotactic protein' [patent_app_type] => 1 [patent_app_number] => 8/436420 [patent_app_country] => US [patent_app_date] => 1995-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9819 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840524.pdf [firstpage_image] =>[orig_patent_app_number] => 436420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3991592 [patent_doc_number] => 05922325 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Synergistic neutralization of HIV-1 by human monoclonal antibodies and other antibodies directed against the v3 loop and the CD-4 binding site of GP-120,and the use for immunotherapy of HIV-1 infection' [patent_app_type] => 1 [patent_app_number] => 8/447214 [patent_app_country] => US [patent_app_date] => 1995-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 15645 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922325.pdf [firstpage_image] =>[orig_patent_app_number] => 447214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3998988 [patent_doc_number] => 05858726 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Self-assembling replication defective hybrid virus particles' [patent_app_type] => 1 [patent_app_number] => 8/442471 [patent_app_country] => US [patent_app_date] => 1995-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8611 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858726.pdf [firstpage_image] =>[orig_patent_app_number] => 442471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3787003 [patent_doc_number] => 05780038 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'HIV-2 envelope polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/433036 [patent_app_country] => US [patent_app_date] => 1995-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 20 [patent_no_of_words] => 9862 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780038.pdf [firstpage_image] =>[orig_patent_app_number] => 433036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3933719 [patent_doc_number] => 05871747 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Antigen-carrying microparticles and their use in the indication of humoral or cellular responses' [patent_app_type] => 1 [patent_app_number] => 8/397286 [patent_app_country] => US [patent_app_date] => 1995-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 28 [patent_no_of_words] => 9706 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/871/05871747.pdf [firstpage_image] =>[orig_patent_app_number] => 397286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4059579 [patent_doc_number] => 06007817 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-28 [patent_title] => 'Vasopermeability enhancing immunoconjugates' [patent_app_type] => 1 [patent_app_number] => 8/419645 [patent_app_country] => US [patent_app_date] => 1995-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11736 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/007/06007817.pdf [firstpage_image] =>[orig_patent_app_number] => 419645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3759966 [patent_doc_number] => 05721354 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-24 [patent_title] => 'Human cytomegalovirus DNA sequences' [patent_app_type] => 1 [patent_app_number] => 8/414926 [patent_app_country] => US [patent_app_date] => 1995-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 17919 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/721/05721354.pdf [firstpage_image] =>[orig_patent_app_number] => 414926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1417834 [patent_doc_number] => 06506553 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-14 [patent_title] => 'Method for diagnosis of Epstein-Barr virus associated disease' [patent_app_type] => B1 [patent_app_number] => 08/413233 [patent_app_country] => US [patent_app_date] => 1995-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6606 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506553.pdf [firstpage_image] =>[orig_patent_app_number] => 08413233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3985758 [patent_doc_number] => 05891434 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Monoclonal antibodies to the APO-1 antigen' [patent_app_type] => 1 [patent_app_number] => 8/409338 [patent_app_country] => US [patent_app_date] => 1995-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8755 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891434.pdf [firstpage_image] =>[orig_patent_app_number] => 409338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3987574 [patent_doc_number] => 05985318 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Fusogenic liposomes that are free of active neuraminidase' [patent_app_type] => 1 [patent_app_number] => 8/406101 [patent_app_country] => US [patent_app_date] => 1995-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 29 [patent_no_of_words] => 6290 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985318.pdf [firstpage_image] =>[orig_patent_app_number] => 406101 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3784081 [patent_doc_number] => 05736317 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-07 [patent_title] => 'Human T-cell line infected with HIV-2 which secretes a protein corresponding to native HIV-2 gp160 in an extracellular medium' [patent_app_type] => 1 [patent_app_number] => 8/402481 [patent_app_country] => US [patent_app_date] => 1995-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2817 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/736/05736317.pdf [firstpage_image] =>[orig_patent_app_number] => 402481 [rel_patent_id] =>[rel_patent_doc_number] =>)